The expression of IL4 in the tumor microenvironment can improve tumor growth and the blockade of IL4 can delay the growth [70] and can also improve immunotherapies (in mice models) such as CpG ODN or anti-OX40 AB [71]. This evidence concerns the gene TNFRSF4 and neoplasm.